ViewPoints Interview: Biogen’s Monica Mann Shares Insight on Plegridy to Treat Multiple Sclerosis
Shots: The approval is based on P-III study results assessing Linzess (290 mcg) vs PBO in 839 patients in ratio the (1:1) with IBS-C in adults for 12 weeks The P-III study demonstrated 1EP & 2EP as Abdominal Pain/Discomfort Responders (60% vs 48.8%) & IBS Degree of Relief Responders (31.7% vs 15.4%) respectively Linaclotide is […]Read More
